Patent · US Active

5,5-disubstituted luciferins and their use in luciferase-based assays

US10400264B2 · kind B2 · utility

2Cited by

2References

30Claims

0Family size

Assignee

Promega Corporation · US

Inventors

Lance P. Encell · Fitchburg, US
Mary Hall · Waunakee, US
Michael Killoran · Madison, US
Thomas Kirkland · Atascadero, US
Poncho Meisenheimer · San Luis Obispo, US
Ce Shi · San Luis Obispo, US

Key dates

Filing date	Dec 1, 2017
Grant date	Sep 3, 2019
Priority date	—
Expiry date	Dec 1, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N21/763
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are luciferin analogs, methods for making the analogs, kits including the analogs, and methods of using the compounds for the detection of luminescence in luciferase-based assays.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.